Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
- PMID: 35473844
- DOI: 10.4187/respcare.10067
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
Conflict of interest statement
The authors have disclosed no conflicts of interest.
Comment on
-
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.Respir Care. 2021 Dec;66(12):1805-1814. doi: 10.4187/respcare.08779. Epub 2021 Sep 21. Respir Care. 2021. PMID: 34548407 Free PMC article.
-
Timing of Tocilizumab Use and COVID-19.Respir Care. 2022 Mar;67(3):381-382. doi: 10.4187/respcare.09678. Respir Care. 2022. PMID: 35190482 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous